Jujutsu Kaisen Modulo reunites Yuji Itadori with one of the best villains in the series. Read on to find out more.

Shake Shack has transformed into a disciplined, margin-expanding growth business with scalable unit economics and a clear path to increasing locations.

ZIM Integrated stock trades below its $3.01B cash, hinting at undervaluation amid takeover rumors and limited downside. See ...

Acquired Business Expected to Generate $300 Million in Revenue in 12 Months Post-Close, with 70% Gross MarginHigh-Growth AI Datacenter-Comms Represents ~75% of Acquired Revenue Accelerates SiTime’s ...

The New York Knicks are back! Following a stretch so disappointing that it felt as if the team was a loss or two away from ...

Amateur mathematicians are using artificial intelligence chatbots to solve long-standing problems, in a move that has taken professionals by surprise. While the problems in question aren’t the most ...

Gege Akutami and Yuji Iwasaki's sequel manga remembered to make a worthwhile story the connective tissue of its sorcery fighting series. Reading time 4 minutes When Jujutsu Kaisen‘s manga finally ...

Clear some space on your schedule as the Jujutsu Kaisen Modulo universe is gearing up for its next big update. As Chapter 17 approaches, excitement is steadily rising over when the new installment ...

Cathlyn Melo is an experienced anime writer from the Philippines with a Master in Business Administration. She was once a hospital employee before deciding to pursue her passion for anime and manga ...

Get a fresh look at Modulus in this latest trailer for the upcoming factory automation game. Modulus version 1.0 will be available on PC in 2026, and an expanded and updated demo is out now on Steam.

Cathlyn Melo is an experienced anime writer from the Philippines with a Master in Business Administration. She was once a hospital employee before deciding to pursue her passion for anime and manga ...

SAN DIEGO--(BUSINESS WIRE)--Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has ...